TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 2 | 4 | 5 | 13 | -36 | -56 | -11 |
| P | %wins | 100 | 100 | 100 | 75 | 0 | 0 | 63 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/26/17 19:11 | 1/24/17 | DVAX | Dynavax Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | VP | P | 24 | 4.04 | 4 | 6 | 99 | 12 | D | -79 | -85 | -73 | -61 | -11 | -10 | -9 | -7 | 3 | 5 | 6 | 49 | ||
6/30/16 06:51 | 6/28/16 | DVAX | Dynavax Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | VP | P | 20 | 13.68 | 9 | 1 | 32 | 6 | D | -10 | -39 | -41 | -25 | -6 | -5 | -4 | 4 | 1 | 5 | 7 | -22 | -73 | |
5/13/16 09:30 | 5/12/16 | DVAX | Dynavax Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | VP | P | 15 | 15.12 | 18 | 1 | New | 1 | D | 5 | -28 | -43 | -23 | -28 | -34 | -10 | -4 | 5 | 5 | 1 | 11 | -22 | |
10/9/15 16:08 | 10/8/15 | DVAX | Dynavax Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | VP | P | 2 | 23.34 | 17 | 0 | New | 0 | D | 94 | 62 | 4 | -17 | -18 | -24 | -2 | -12 | 0 | 2 | 4 | 12 | -14 | -56 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |